Sort
25,944 grants matching “neurodegeneration”
Oxidative DNA Damage And Its Processing
$654,019Vilhelm A Bohr · Aging · Z01 · FY2007 · AG
Oxidative DNA Damage Repair in Premature Aging and Neurodegeneration
$653,928David Wilson · National Institute On Aging · ZIA · FY2016 · AG
Discovery of functionally selective Alzheimer's disease therapeutics
$653,795John A Schetz · University Of North Texas Hlth Sci Ctr · R01 · FY2017 · AG
The Alzheimer's Disease Resiliome: Pathway Analysis and Drug Discovery.
$653,770Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2023 · AG
Single nucleus gene expression in moderate and compulsive drug self-administration in a rodent model of HIV
$653,746Pietro P Sanna · Scripps Research Institute, The · U01 · FY2025 · DA
MRI predictors of disease and disability progression in African Americans with multiple sclerosis
$653,611Fred D Lublin · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · NS
Preclinical trial for dysarthria treatment in Parkinson disease
$653,455Michelle Renee Ciucci · University Of Wisconsin-Madison · R01 · FY2022 · DC
Preclinical trial for dysarthria treatment in Parkinson disease
$653,455Michelle Renee Ciucci · University Of Wisconsin-Madison · R01 · FY2024 · DC
Preclinical trial for dysarthria treatment in Parkinson disease
$653,455Michelle Renee Ciucci · University Of Wisconsin-Madison · R01 · FY2025 · DC
Preclinical trial for dysarthria treatment in Parkinson disease
$653,455Michelle Renee Ciucci · University Of Wisconsin-Madison · R01 · FY2023 · DC
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
$653,216Laxmikant S Deshpande · Virginia Commonwealth University · UH3 · FY2025 · NS
Non-invasive Imaging of Pathological Fibrin Deposition and its Effect on Progressive Neurodegeneration in the Human Brain: an in vivo longitudinal study
$653,192Caterina Mainero · Massachusetts General Hospital · R01 · FY2025 · NS
Neuropathological Characterization of 'CTE'
$653,160Douglas Hamilton Smith · University Of Pennsylvania · R01 · FY2016 · NS
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
$653,107Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2020 · ES
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
$653,107Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2024 · ES
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
$653,107Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · ES
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
$653,107Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2023 · ES
Mapping the ALS Exposome to Gain New Insights into Disease Risk and Pathogenesis
$653,107Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2022 · ES
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy
$653,076Aaron J Johnson · Mayo Clinic Rochester · R01 · FY2024 · NS
Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD
$653,024Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2019 · NS
Nucleocytoplasmic transport and nuclear pore disruption in ALS/FTD
$653,024Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2020 · NS
SUPRAMOLECULAR ABETA STRUCTURE--GLIAL/NEURONAL RESPONSE
$652,940Evanston Hospital · P01 · FY2001 · AG
Treating with Gamma-Secretase Modulators to Prevent Neurodegeneration in Mouse Models of Down Syndrome and Alzheimer Disease
$652,884William C Mobley · University Of California, San Diego · R01 · FY2021 · AG
Fluid Biomarker Core
$652,619Tharick Pascoal · University Of Pittsburgh At Pittsburgh · P01 · FY2022 · AG
Morphologic/Neurochemical Correlates of Depression in AD
$652,572George S Zubenko · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · MH